Speaker Profile
MD, PhD, Chief Cancer Data Science Laboratory, CCR, NCI
Biography
Eytan Ruppin has served as a professor of Computer Science Medicine since 1995, conducting computational multidisciplinary research spanning computational neuroscience, natural language processing, machine learning and systems biology. In 2014, he joined the University of Maryland as director of its Center for Cioinformatics and Computational Biology (CBCB). In 2018, he moved to the NCI where he founded and is chief of its Cancer Data Science Lab (CDSL). His research is focused on developing new computational approaches for advancing transcriptomics-based precision oncology. Eytan is a member of the editorial board of Molecular Systems Biology, a fellow of the International Society for Computational Biology (ISCB), a recipient of the NCI Director award and the Delano awards and is a co-founder of a few precision medicine startup companies.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Razelle Kurzrock, Medical College of Wisconsin
- PMWC 2024 Award Ceremony:
Luminary Honoree: Catriona Jamieson, UCSD Health
- Keynote: Targeting Cancer Stem Cells in Precision Oncology
- Catriona Jamieson, UCSD Health
- Revolutionizing Clinical Trials: Precision Oncology and Novel Trial Designs (PANEL)
Chair: Razelle Kurzrock, MCW
- Andrea Cercek, Memorial Sloan Kettering
- Apostolia Tsimberidou, MD Anderson
- Ben George, MCW
- Transcriptomics in Precision Oncology: Opportunities and Limitations (PANEL)
Chair: Razelle Kurzrock, MCW
- Andrea Califano, Columbia University
- Charles Perou, University of North Carolina
- Eytan Ruppin, NIH
- Bruce Quinn, Bruce Quinn Assoc LL
- David W. Craig, City of Hope Cancer Center - Legislation Mandating Insurance Coverage for Biomarker Testing
- Kathryn Phillips, UCSF
- Collaborative Frontiers: Transforming Cancer Care Access and Patient Outcomes (PANEL)
Chair: Maggie Rougier-Chapman, Labcorp
- Jennifer Rushton, Baptist Health System San Antonio, TX
- Rebecca Previs, Duke Cancer Institute
- Suzanne Garner, Outcomes4Me
- Taylor Jensen, Labcorp - Exploring the Clinical Utility of Dynamic ctDNA Monitoring
Chair: Lincoln Pasquina, Foundation Medicine
- Hatim Husain, UCSD - Antibody-Drug Conjugates (ADCs): Tracing the Evolution and Forecasting the Future (PANEL)
Chair: Adrian Lee, UPMC
- Sandhya Girish, Gilead
- Neelima Denduluri, Astra Zeneca
- Hope S. Rugo, UCSF - PMWC Showcase
- Michael Milburn, Genecentric Tx
- Robert Cook, Castle Bio
- Mark P. de Souza,SonALAsense, Inc.
- Amrie Grammer, Ampel Biosolutions - NCI Showcase
- Nick Reder, Alpenglow Bio
